First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers
Clinical trial NCT05275855 · COMPLETED
Trial details
- NCT number
- NCT05275855
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-29
- Primary completion
- 2024-12-18
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.